The HerediGene: Population Study was opened to study the genes of hundreds of thousands of participants to better predict and prevent serious diseases. While the study is no longer taking new enrollments, our team is still processing data and gathering important findings.

Genes control everything from your height, to how you respond to certain medications, and even your risk for developing disease. The more we know about DNA, the more we can personalize healthcare at a genetic level. We want to discover new connections so we can prevent disease and improve treatment.

Intermountain Health is leading other health systems across the world in precision genomics, changing the way patients plan for their health and receive care when they need it. By studying the genetic makeup of such a large group, we have the potential to make discoveries that may allow us to predict individuals’ risk of disease and even prevent diseases from developing.

It is predicted that a very small percentage – about 3% of the population – will receive a report identifying a known, disease-causing variant. You can choose to learn your results or refuse them. We will only report on variants we can treat and/or manage. HerediGene: Population Study results do NOT replace clinical testing.  

Most participants will NOT hear back on the findings. Negative results, in which no known or treatable disease-causing gene variants were found, will not be reported back. A negative result from HerediGene does not mean you are free from the risk of genetic conditions.

Talk to your doctor or genetic counselor if you have a family history of hereditary disease or believe you are at risk for hereditary disease.